Aarkstore.com announces, The Latest market research report is available inits vast collection:Reata Pharmaceuticals, Inc. – Product Pipeline Review – 2012http://www.aarkstore.com/reports/Reata-Pharmaceuticals-Inc-Product-Pipeline-Review-2012-217912.htmlRSS link of Global Markets Directhttp://www.aarkstore.com/feeds/Global-Markets-Direct.xmlSummaryGlobal Market Direct’s pharmaceuticals report, “Reata Pharmaceuticals, Inc. -Product Pipeline Review - 2012” provides data on the Reata Pharmaceuticals, Inc.’sresearch and development focus. The report includes information on currentdevelopmental pipeline, complete with latest updates, and features on discontinuedand dormant projects.This report is built using data and information sourced from Global Markets Direct’sproprietary databases, Reata Pharmaceuticals, Inc.’s corporate website, SEC filings,investor presentations and featured press releases, both from ReataPharmaceuticals, Inc. and industry-specific third party sources, put together byGlobal Markets Direct’s team.Scope- Reata Pharmaceuticals, Inc. - Brief Reata Pharmaceuticals, Inc. overview includingbusiness description, key information and facts, and its locations and subsidiaries.- Review of current pipeline of Reata Pharmaceuticals, Inc. human therapeuticdivision.
- Overview of pipeline therapeutics across various therapy areas.- Coverage of current pipeline molecules in various stages of drug development,including the combination treatment modalities, across the globe.Table of contents:List of Tables 4List of Figures 5Reata Pharmaceuticals, Inc. Snapshot 6Reata Pharmaceuticals, Inc. Overview 6Key Information 6Key Facts 6Reata Pharmaceuticals, Inc. – Research and Development Overview 7Key Therapeutic Areas 7Reata Pharmaceuticals, Inc. – Pipeline Review 9Pipeline Products by Stage of Development 9Pipeline Products – Monotherapy 10Reata Pharmaceuticals, Inc. – Pipeline Products Glance 11Reata Pharmaceuticals, Inc. – Late Stage Pipeline 11Phase III Products/Combination Treatment Modalities 11Reata Pharmaceuticals, Inc. Clinical Stage Pipeline Products 12Phase II Products/Combination Treatment Modalities 12Reata Pharmaceuticals, Inc. – Early Stage Pipeline Products 13Pre-Clinical Products/Combination Treatment Modalities 13Reata Pharmaceuticals, Inc. – Drug Profiles 14AIM For AutoImmune Disease 14Product Description 14Mechanism of Action 14R&D Progress 14AIMs for CNS Diseases 15Product Description 15Mechanism of Action 15R&D Progress 15AIMs For Respiratory Diseases 16Product Description 16Mechanism of Action 16R&D Progress 16
Bardoxolone Methyl 17Product Description 17Mechanism of Action 17R&D Progress 17RTA 403 19Product Description 19List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Product Pipeline Review – 2012http://www.aarkstore.com/search/viewresults.asp?search=Product PipelineReview&PubId=&pagenum=1Proteo, Inc. – Product Pipeline Review – 2012Reata Pharmaceuticals, Inc. – Product Pipeline Review – 2012Recoly N.V. – Product Pipeline Review – 2012S.L.A. Pharma AG – Product Pipeline Review – 2012SBI Biotech Co., Ltd. – Product Pipeline Review – 2012Sentinel Oncology Limited – Product Pipeline Review – 2012Sentinel Oncology Limited – Product Pipeline Review – 2012SIFI Pharma – Product Pipeline Review – 2012
Snowdon Inc. – Product Pipeline Review – 2012Stelic Institute & Co. – Product Pipeline Review – 2012SWITCH Biotech LLC – Product Pipeline Review – 2012Teikoku Pharma USA, Inc. – Product Pipeline Review – 2012TetraLogic Pharmaceuticals – Product Pipeline Review – 2012Tranzyme Pharma, Inc. – Product Pipeline Review – 2012Unigene Laboratories, Inc. – Product Pipeline Review – 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcarehttp://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals andHealthcare&PubId=&pagenum=1You can also request for sample page of above mention reports email@example.comFor More details Plz do contact :